Mannitol dose requirements in brain-injured patients

Area of Science:

• Neurosurgery
• Critical Care Medicine
• Pharmacology

Background:

• Optimal mannitol use for reducing intracranial pressure (ICP) is not well-defined.
• Acute head injury often leads to elevated ICP, requiring effective management.

Purpose of the Study:

• To determine the dose-response relationship of mannitol for ICP reduction.
• To establish the required osmotic gradient and time course of ICP reduction with mannitol.

Main Methods:

• Eight acute head injury patients with elevated ICP were studied.
• Mannitol was administered in boluses of 0.25, 0.5, and 1 gm/kg.
• ICP was monitored via ventriculostomy; ventilation and paralysis were controlled.

Main Results:

• A 0.25 gm/kg dose of mannitol significantly reduced ICP (p < 0.01).
• ICP reduction was equivalent across all tested mannitol doses (0.25, 0.5, 1 gm/kg).
• Serum osmolality increases of ≥10 mOsm correlated with ICP reduction.

Conclusions:

• Smaller mannitol doses are effective for acute ICP reduction in head injury.
• Smaller, more frequent doses may be preferable to avoid osmotic disequilibrium and dehydration.
• Further research may clarify optimal dosing strategies for sustained ICP control.